Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms

William Tapper, Amy V. Jones, Robert Kralovics, Ashot S. Harutyunyan, Katerina Zoi, William Leung, Anna L. Godfrey, Paola Guglielmelli, Alison Callaway, Daniel Ward, Paula Aranaz, Helen E. White, Katherine Waghorn, Feng Lin, Andrew Chase, E. Joanna Baxter, Cathy MacLean, Jyoti Nangalia, Edwin Chen, Paul EvansMichael Short, Andrew Jack, Louise Wallis, David Oscier, Andrew S. Duncombe, Anna Schuh, Adam J. Mead, Michael Griffiths, Joanne Ewing, Rosemary E. Gale, Susanne Schnittger, Torsten Haferlach, Frank Stegelmann, Konstanze Döhner, Harald Grallert, Konstantin Strauch, Toshiko Tanaka, Stefania Bandinelli, Andreas Giannopoulos, Lisa Pieri, Carmela Mannarelli, Heinz Gisslinger, Giovanni Barosi, Mario Cazzola, Andreas Reiter, Claire Harrison, Peter Campbell, Anthony R. Green, Alessandro Vannucchi, Nicholas C P Cross

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Clonal proliferation in myeloproliferative neoplasms (MPN) is driven by somatic mutations in JAK2, CALR or MPL, but the contribution of inherited factors is poorly characterized. Using a three-stage genome-wide association study of 3,437 MPN cases and 10,083 controls, we identify two SNPs with genome-wide significance in JAK2V617F -negative MPN: rs12339666 (JAK2; meta-analysis P=1.27 × 10-10) and rs2201862 (MECOM; meta-analysis P=1.96 × 10-9). Two additional SNPs, rs2736100 (TERT) and rs9376092 (HBS1L/MYB), achieve genome-wide significance when including JAK2V617F-positive cases. rs9376092 has a stronger effect in JAK2V617F-negative cases with CALR and/or MPL mutations (Breslow-Day P=4.5 × 10-7), whereas in JAK2V617F-positive cases rs9376092 associates with essential thrombocythemia (ET) rather than polycythemia vera (allelic x2 P=7.3 × 10-7). Reduced MYB expression, previously linked to development of an ET-like disease in model systems, associates with rs9376092 in normal myeloid cells. These findings demonstrate that multiple germline variants predispose to MPN and link constitutional differences in MYB expression to disease phenotype.

Original languageEnglish
Article number6691
JournalNature Communications
Volume6
DOIs
Publication statusPublished - Apr 13 2015

Fingerprint

neoplasms
genome
Genes
Essential Thrombocythemia
mutations
polycythemia
Single Nucleotide Polymorphism
Meta-Analysis
Neoplasms
Genome
Polycythemia Vera
Mutation
phenotype
Genome-Wide Association Study
Myeloid Cells
Phenotype
cells

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemistry(all)
  • Physics and Astronomy(all)

Cite this

Tapper, W., Jones, A. V., Kralovics, R., Harutyunyan, A. S., Zoi, K., Leung, W., ... Cross, N. C. P. (2015). Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms. Nature Communications, 6, [6691]. https://doi.org/10.1038/ncomms7691

Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms. / Tapper, William; Jones, Amy V.; Kralovics, Robert; Harutyunyan, Ashot S.; Zoi, Katerina; Leung, William; Godfrey, Anna L.; Guglielmelli, Paola; Callaway, Alison; Ward, Daniel; Aranaz, Paula; White, Helen E.; Waghorn, Katherine; Lin, Feng; Chase, Andrew; Joanna Baxter, E.; MacLean, Cathy; Nangalia, Jyoti; Chen, Edwin; Evans, Paul; Short, Michael; Jack, Andrew; Wallis, Louise; Oscier, David; Duncombe, Andrew S.; Schuh, Anna; Mead, Adam J.; Griffiths, Michael; Ewing, Joanne; Gale, Rosemary E.; Schnittger, Susanne; Haferlach, Torsten; Stegelmann, Frank; Döhner, Konstanze; Grallert, Harald; Strauch, Konstantin; Tanaka, Toshiko; Bandinelli, Stefania; Giannopoulos, Andreas; Pieri, Lisa; Mannarelli, Carmela; Gisslinger, Heinz; Barosi, Giovanni; Cazzola, Mario; Reiter, Andreas; Harrison, Claire; Campbell, Peter; Green, Anthony R.; Vannucchi, Alessandro; Cross, Nicholas C P.

In: Nature Communications, Vol. 6, 6691, 13.04.2015.

Research output: Contribution to journalArticle

Tapper, W, Jones, AV, Kralovics, R, Harutyunyan, AS, Zoi, K, Leung, W, Godfrey, AL, Guglielmelli, P, Callaway, A, Ward, D, Aranaz, P, White, HE, Waghorn, K, Lin, F, Chase, A, Joanna Baxter, E, MacLean, C, Nangalia, J, Chen, E, Evans, P, Short, M, Jack, A, Wallis, L, Oscier, D, Duncombe, AS, Schuh, A, Mead, AJ, Griffiths, M, Ewing, J, Gale, RE, Schnittger, S, Haferlach, T, Stegelmann, F, Döhner, K, Grallert, H, Strauch, K, Tanaka, T, Bandinelli, S, Giannopoulos, A, Pieri, L, Mannarelli, C, Gisslinger, H, Barosi, G, Cazzola, M, Reiter, A, Harrison, C, Campbell, P, Green, AR, Vannucchi, A & Cross, NCP 2015, 'Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms', Nature Communications, vol. 6, 6691. https://doi.org/10.1038/ncomms7691
Tapper, William ; Jones, Amy V. ; Kralovics, Robert ; Harutyunyan, Ashot S. ; Zoi, Katerina ; Leung, William ; Godfrey, Anna L. ; Guglielmelli, Paola ; Callaway, Alison ; Ward, Daniel ; Aranaz, Paula ; White, Helen E. ; Waghorn, Katherine ; Lin, Feng ; Chase, Andrew ; Joanna Baxter, E. ; MacLean, Cathy ; Nangalia, Jyoti ; Chen, Edwin ; Evans, Paul ; Short, Michael ; Jack, Andrew ; Wallis, Louise ; Oscier, David ; Duncombe, Andrew S. ; Schuh, Anna ; Mead, Adam J. ; Griffiths, Michael ; Ewing, Joanne ; Gale, Rosemary E. ; Schnittger, Susanne ; Haferlach, Torsten ; Stegelmann, Frank ; Döhner, Konstanze ; Grallert, Harald ; Strauch, Konstantin ; Tanaka, Toshiko ; Bandinelli, Stefania ; Giannopoulos, Andreas ; Pieri, Lisa ; Mannarelli, Carmela ; Gisslinger, Heinz ; Barosi, Giovanni ; Cazzola, Mario ; Reiter, Andreas ; Harrison, Claire ; Campbell, Peter ; Green, Anthony R. ; Vannucchi, Alessandro ; Cross, Nicholas C P. / Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms. In: Nature Communications. 2015 ; Vol. 6.
@article{1c083ce96db04225b7ed24a9d80e97a1,
title = "Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms",
abstract = "Clonal proliferation in myeloproliferative neoplasms (MPN) is driven by somatic mutations in JAK2, CALR or MPL, but the contribution of inherited factors is poorly characterized. Using a three-stage genome-wide association study of 3,437 MPN cases and 10,083 controls, we identify two SNPs with genome-wide significance in JAK2V617F -negative MPN: rs12339666 (JAK2; meta-analysis P=1.27 × 10-10) and rs2201862 (MECOM; meta-analysis P=1.96 × 10-9). Two additional SNPs, rs2736100 (TERT) and rs9376092 (HBS1L/MYB), achieve genome-wide significance when including JAK2V617F-positive cases. rs9376092 has a stronger effect in JAK2V617F-negative cases with CALR and/or MPL mutations (Breslow-Day P=4.5 × 10-7), whereas in JAK2V617F-positive cases rs9376092 associates with essential thrombocythemia (ET) rather than polycythemia vera (allelic x2 P=7.3 × 10-7). Reduced MYB expression, previously linked to development of an ET-like disease in model systems, associates with rs9376092 in normal myeloid cells. These findings demonstrate that multiple germline variants predispose to MPN and link constitutional differences in MYB expression to disease phenotype.",
author = "William Tapper and Jones, {Amy V.} and Robert Kralovics and Harutyunyan, {Ashot S.} and Katerina Zoi and William Leung and Godfrey, {Anna L.} and Paola Guglielmelli and Alison Callaway and Daniel Ward and Paula Aranaz and White, {Helen E.} and Katherine Waghorn and Feng Lin and Andrew Chase and {Joanna Baxter}, E. and Cathy MacLean and Jyoti Nangalia and Edwin Chen and Paul Evans and Michael Short and Andrew Jack and Louise Wallis and David Oscier and Duncombe, {Andrew S.} and Anna Schuh and Mead, {Adam J.} and Michael Griffiths and Joanne Ewing and Gale, {Rosemary E.} and Susanne Schnittger and Torsten Haferlach and Frank Stegelmann and Konstanze D{\"o}hner and Harald Grallert and Konstantin Strauch and Toshiko Tanaka and Stefania Bandinelli and Andreas Giannopoulos and Lisa Pieri and Carmela Mannarelli and Heinz Gisslinger and Giovanni Barosi and Mario Cazzola and Andreas Reiter and Claire Harrison and Peter Campbell and Green, {Anthony R.} and Alessandro Vannucchi and Cross, {Nicholas C P}",
year = "2015",
month = "4",
day = "13",
doi = "10.1038/ncomms7691",
language = "English",
volume = "6",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "NLM (Medline)",

}

TY - JOUR

T1 - Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms

AU - Tapper, William

AU - Jones, Amy V.

AU - Kralovics, Robert

AU - Harutyunyan, Ashot S.

AU - Zoi, Katerina

AU - Leung, William

AU - Godfrey, Anna L.

AU - Guglielmelli, Paola

AU - Callaway, Alison

AU - Ward, Daniel

AU - Aranaz, Paula

AU - White, Helen E.

AU - Waghorn, Katherine

AU - Lin, Feng

AU - Chase, Andrew

AU - Joanna Baxter, E.

AU - MacLean, Cathy

AU - Nangalia, Jyoti

AU - Chen, Edwin

AU - Evans, Paul

AU - Short, Michael

AU - Jack, Andrew

AU - Wallis, Louise

AU - Oscier, David

AU - Duncombe, Andrew S.

AU - Schuh, Anna

AU - Mead, Adam J.

AU - Griffiths, Michael

AU - Ewing, Joanne

AU - Gale, Rosemary E.

AU - Schnittger, Susanne

AU - Haferlach, Torsten

AU - Stegelmann, Frank

AU - Döhner, Konstanze

AU - Grallert, Harald

AU - Strauch, Konstantin

AU - Tanaka, Toshiko

AU - Bandinelli, Stefania

AU - Giannopoulos, Andreas

AU - Pieri, Lisa

AU - Mannarelli, Carmela

AU - Gisslinger, Heinz

AU - Barosi, Giovanni

AU - Cazzola, Mario

AU - Reiter, Andreas

AU - Harrison, Claire

AU - Campbell, Peter

AU - Green, Anthony R.

AU - Vannucchi, Alessandro

AU - Cross, Nicholas C P

PY - 2015/4/13

Y1 - 2015/4/13

N2 - Clonal proliferation in myeloproliferative neoplasms (MPN) is driven by somatic mutations in JAK2, CALR or MPL, but the contribution of inherited factors is poorly characterized. Using a three-stage genome-wide association study of 3,437 MPN cases and 10,083 controls, we identify two SNPs with genome-wide significance in JAK2V617F -negative MPN: rs12339666 (JAK2; meta-analysis P=1.27 × 10-10) and rs2201862 (MECOM; meta-analysis P=1.96 × 10-9). Two additional SNPs, rs2736100 (TERT) and rs9376092 (HBS1L/MYB), achieve genome-wide significance when including JAK2V617F-positive cases. rs9376092 has a stronger effect in JAK2V617F-negative cases with CALR and/or MPL mutations (Breslow-Day P=4.5 × 10-7), whereas in JAK2V617F-positive cases rs9376092 associates with essential thrombocythemia (ET) rather than polycythemia vera (allelic x2 P=7.3 × 10-7). Reduced MYB expression, previously linked to development of an ET-like disease in model systems, associates with rs9376092 in normal myeloid cells. These findings demonstrate that multiple germline variants predispose to MPN and link constitutional differences in MYB expression to disease phenotype.

AB - Clonal proliferation in myeloproliferative neoplasms (MPN) is driven by somatic mutations in JAK2, CALR or MPL, but the contribution of inherited factors is poorly characterized. Using a three-stage genome-wide association study of 3,437 MPN cases and 10,083 controls, we identify two SNPs with genome-wide significance in JAK2V617F -negative MPN: rs12339666 (JAK2; meta-analysis P=1.27 × 10-10) and rs2201862 (MECOM; meta-analysis P=1.96 × 10-9). Two additional SNPs, rs2736100 (TERT) and rs9376092 (HBS1L/MYB), achieve genome-wide significance when including JAK2V617F-positive cases. rs9376092 has a stronger effect in JAK2V617F-negative cases with CALR and/or MPL mutations (Breslow-Day P=4.5 × 10-7), whereas in JAK2V617F-positive cases rs9376092 associates with essential thrombocythemia (ET) rather than polycythemia vera (allelic x2 P=7.3 × 10-7). Reduced MYB expression, previously linked to development of an ET-like disease in model systems, associates with rs9376092 in normal myeloid cells. These findings demonstrate that multiple germline variants predispose to MPN and link constitutional differences in MYB expression to disease phenotype.

UR - http://www.scopus.com/inward/record.url?scp=84927153553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927153553&partnerID=8YFLogxK

U2 - 10.1038/ncomms7691

DO - 10.1038/ncomms7691

M3 - Article

AN - SCOPUS:84927153553

VL - 6

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 6691

ER -